{
  "id": "clinical#screening_cues_9d77a80e",
  "content": "8. Recurrent sedative, hypnotic, or anxiolytic use in situations\nin which it is physically hazardous (e.g., driving an automo-\nbile or operating a machine when impaired by sedative, hyp-\nnotic, or anxiolytic use).\n9. Sedative, hypnotic, or anxiolytic use is continued despite\nknowledge of having a persistent or recurrent physical or\npsychological problem that is likely to have been caused or\nexacerbated by the sedative, hypnotic, or anxiolytic.\n10. Tolerance, as defined by either of the following:\na. A need for markedly increased amounts of the sedative,\nhypnotic, or anxiolytic to achieve intoxication or desired\neffect.\nb. A markedly diminished effect with continued use of the\nsame amount of the sedative, hypnotic, or anxiolytic.\nNote: This criterion is not considered to be met for individu-\nals taking sedatives, hypnotics, or anxiolytics under medical\nsupervision.\n11. Withdrawal, as manifested by either of the following:\na. The characteristic withdrawal syndrome for sedatives,\nhypnotics, or anxiolytics (refer to Criteria A and B of the\ncriteria set for sedative, hypnotic, or anxiolytic withdraw-\nal, pp. 265–266).\nb. Sedatives, hypnotics, or anxiolytics (or a closely related\nsubstance, such as alcohol) are taken to relieve or avoid\nwithdrawal symptoms.",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues",
      "referral"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues 8. Recurrent sedative, hypnotic, or anxiolytic use in situations\nin which it is physically hazardous (e.g., driving an automo-\nbile or operating a machine when impaired by sedative, hyp-\nnotic, or anxiolytic use).\n9. Sedative, hypnotic, or anxiolytic use is continued despite\nknowledge of having a persistent or recurrent physical or\npsychological problem that is likely to have been caused or\nexacerbated by the sedative, hypnotic, or anxiolytic.\n10. Tolerance, as defined by either of the following:\na. A need for markedly increased amounts of the sedative,\nhypnotic, or anxiolytic to achieve intoxication or desired\neffect.\nb. A markedly diminished effect with continued use of the\nsame amount of the sedative, hypnotic, or anxiolytic.\nNote: This criterion is not considered to be met for individu-\nals taking sedatives, hypnotics, or anxiolytics under medical\nsupervision.\n11. Withdrawal, as manifested by either of the following:\na. The characteristic withdrawal syndrome for sedatives,\nhypnotics, or anxiolytics (refer to Criteria A and B of the\ncriteria set for sedative, hypnotic, or anxiolytic withdraw-\nal, pp. 265–266).\nb. Sedatives, hypnotics, or anxiolytics (or a closely related\nsubstance, such as alcohol) are taken to relieve or avoid\nwithdrawal symptoms. 8. recurrent sedative, hypnotic, or anxiolytic use in situations\nin which it is physically hazardous (e.g., driving an automo-\nbile or operating a machine when impaired by sedative, hyp-\nnotic, or anxiolytic use)."
}